28th Feb 2008 08:16
Advanced Medical Solutions Grp PLC28 February 2008 TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of existingshares to which voting rights are attached: Advanced Medical Solutions 2. Reason for notification (yes/no) An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to notificationobligation: AXA S.A, 25 Avenue Matignon, 75008 Paris and its group companies 4. Full name of shareholder(s) (if different from3): 5. Date of transaction (and date on which thethreshold is crossed or reached if different): 26/02/08 6. Date on which issuer notified: 27/02/08 7. Threshold(s) that is/are crossed or reached: 13% 8: Notified DetailsA: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transactionshares the triggering transactionIf possible use Number of Number of Number of Number of voting rights Percentage of votingISIN code shares voting shares rights rights Direct Indirect Direct Indirect Ordinary 5p shares 18,946,661 18,946,661 451,161 415,161 18,697,057 0.29 13.07 GB0004536594 B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of votinginstrument period/date that may be acquired rights (if the instrument exercised/converted) Total (A+B) Number of voting rights Percentage of voting rights 19,112,218 13.36 9. Chain of controlled undertakings through which the voting rights and /or thefinancial instruments are effectively held, if applicable: Name of the Company/Fund No of shares % of issued share cap Sun Life Pensions Mgmt Ltd 15,161 0.01 DirectSun Life Pensions Mgmt Ltd 400,000 0.28 DirectAXA Framlington 10,000,000 6.99 Framlington Innovative Growth IndirectAXA Framlington 5,100,000 3.56 Health IndirectFramlington onshore private clients 2,631,500 1.84 IndirectAWF Framlington Health 965,557 0.67 Indirect Total Direct 415,161 0.29 Total Indirect 18,697,057 13.07 Total 19,112,218 13.36 Proxy Voting: 10. Name of proxy holder: N/A 11. Number of voting rights proxy holder will cease N/Ato hold: 12. Date on which proxy holder will cease to hold N/Avoting rights: 13. Additional information: 14 Contact name: Mary Tavener 15. Contact telephone name: +44 (0) 1606 545509 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group